Skip to content
Clinical Trials – home
Tg Therapeutics Inc.
Sponsor

Tg Therapeutics Inc.

United States 3020 Carrington Mill Boulevard Suite 475, 27560-5435, United States

About the sponsor

Tg Therapeutics Inc. focuses on relapsing multiple sclerosis and related relapsing disease presentations, with clinical activity centered on long-term safety, efficacy, and radiological outcomes in people living with active disease.

  • Relapsing forms of multiple sclerosis
  • Relapsing multiple sclerosis
  • Radiological disease activity

The sponsor’s work in this area includes adult and pediatric populations, reflecting interest across different stages of multiple sclerosis care.

About Specializations

Tg Therapeutics Inc. runs clinical trials in conditions such as Relapsing multiple sclerosis, Myasthenia gravis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

6 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ublituximab
  • Sponsor:Tg Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cetirizine
  • Sponsor:Tg Therapeutics Inc.
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Fingolimod
  • Sponsor:Tg Therapeutics Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years
  • Substances:Ublituximab
  • Sponsor:Tg Therapeutics Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Ublituximab
  • Sponsor:Tg Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cetirizine
  • Sponsor:Tg Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.